×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 5 Track A: Improving Access to Pediatric Medicines and Formulations in Canada
Session Chair(s)
Patrick Fandja, MBA, MS
Director, Bureau of Biologics, Radiopharmaceuticals and Self-care products
Health Canada, Canada
This session will bring together the industry, clinician and regulator to discuss the challenges and opportunities to improve access to the pediatric medicines and formulations in Canada.
Learning Objective : At the conclusion of this session, participants should be able to:
- Discuss lessons learned from regional policy reform that has shaped pediatric medicines development globally
- Discuss the opportunities and challenges related to pediatric formulations
- Outline Health Canada’s initiatives aimed at improving access to pediatric medicines
Speaker(s)
Speaker
Christina Bucci-Rechtweg, MD
Novartis , United States
Global Head, Maternal Health and Pediatric Regulatory Policy
Speaker
Andrea Gilpin, PhD, MBA, MS
The Rosalind and Morris Goodman Family Pediatric Formulations Centre , Canada
General Manager
Speaker
Alysha Croker, PhD
Health Canada, Canada
Director, Centre for Policy, Pediatrics and International Collaboration, BRDD